Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACT-TB: Antibiotics for TB Exclusion in Primary Care
NCT03545373Phase 3Completed
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- Feb 2019
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of azithromycin, amoxicillin in pneumonia, respiratory tract infection (RTI), sponsored by London School of Hygiene & Tropical Medicine. Started Feb 2019; status: completed.
02
Drugs
azithromycinamoxicillin
03
Conditions
pneumoniarespiratory tract infection (RTI)
Beyond the preview
Go deeper on NCT03545373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03545373.